Cat.#: ACPP-1492
Despition | PGLYRP1 Human Recombinant |
SIZE | 2 µg |
Purity | Purity as determined by densitometric image analysis is > 90%. |
Form | Filtered White lyophilized (freeze-dried) powder. |
Storage | Lyophilized was stored at -20°C to -80°C, while reconstituted was aliquot and stored at -80°C. Avoid freeze/thaw cycles. |
Shipping | Shipped at 4°C |
Citation Guidance | If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. |
Cat.# | Name | Size | Price |
---|---|---|---|
ACPP-1400 | ACTH (AC1400) | 2 mg | inquiry |
ACPP-1670 | Mouse BDNF Protein (AC1670) | 2 µg | inquiry |
ACPP-1320 | FGFR4 Blocking Peptide (AC1320) | 250 µg | inquiry |
ACPP-1684 | Human GNB3 Protein (AC1684) | 5 µg | inquiry |
ACPP-1817 | Human NT 4 Protein (AC1817) | 20 µg | inquiry |
ACPP-1061 | Recombinant Human DLK-1 Protein (Fc Tag) (AC1061) | 50 µg | inquiry |
ACPP-1211 | Beta crystallin S Blocking Peptide (AC1211) | 250 µg | inquiry |
ACPP-1327 | Dopamine Receptor D1 Blocking Peptide (AC1327) | 250 µg | inquiry |
ACPP-1135 | ACTH Blocking Peptide (AC1135) | 250 µg | inquiry |
ACPP-1574 | Human NDUFS4 Protein (AC1574) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.